Related Experiment Video
Updated: Jul 11, 2025
08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
12.6K
Causes and consequences of clonal hematopoiesis
Lachelle D Weeks1,2,3, Benjamin L Ebert1,2,3,4
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood
|November 6, 2023
Summary
Clonal hematopoiesis (CH), driven by mutations in hematopoietic stem cells, predicts cancer and mortality. Understanding CH origins and risk factors is crucial for managing these premalignant conditions.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Clonal hematopoiesis (CH) involves expanded hematopoietic stem and progenitor cell (HSPC) clones, increasing with age.
- CH arises from somatic mutations or chromosomal abnormalities, acting as a premalignant state for hematologic cancers.
- CH is linked to nonmalignant disorders and elevated overall mortality, potentially via inflammatory cytokines.
Conclusions:
- CH is a significant risk factor for hematologic malignancies and mortality.
- Inflammatory cytokines released due to CH mutations may drive nonmalignant disorders.
- Risk stratification and management strategies are essential for patients with CH.
Related Concept Videos
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:21Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
01:20Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:27Disorders of Leukocytes
963
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
963